Ex vivo programmed cell death and the prediction of response to chemotherapy-Reference-Cited by-同舟云学术

Ex vivo programmed cell death and the prediction of response to chemotherapy

Published:2006-04 Issue:2 Volume:7 Page:103-110
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Nagourney Robert A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11864-006-0045-2.pdf

Reference41 articles.

1. Black MM, Spear FD: Further observations on the effects of cancer chemotherapeutic agents on the in vitro dehydrogenase activity of cancer tissue. J Natl Cancer Inst 1954, 14:1147–1158.

2. Salmon SE, Hamburger AW, Soehnlen BS, et al.:Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med 1978, 298:1321–1327.

3. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972, 26:239–257. This landmark paper describes the discovery of apoptosis as a biological process of profound importance in human disease. The authors coined the term “apoptosis” from the Greek, regarding the orchestrated elimination of abnormal or unnecessary cells in metazoan species.

4. Reed JC: Dysregulation of apoptosis in cancer. J Clin Oncol 1999, 17:2941–2953. This excellent overview of the dysregulation of apoptosis establishes the primacy of survival pathways in human carcinogenesis.

5. Ellis HM, Horvitz HR: Genetic control of programmed cell death in the nematode C. Elegans. Cell 1986, 44:817–829.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Targeting of P53: A Comparative Analysis of APR-246 and COTI-2 in Human Tumor Primary Culture 3-D Explants;Genes;2023-03-19

2. A framework for fibrolamellar carcinoma research and clinical trials;Nature Reviews Gastroenterology & Hepatology;2022-02-21

3. Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis;Gynecologic Oncology;2021-10

4. Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin;European Journal of Surgical Oncology;2021-04

5. Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 7;Journal of Gastrointestinal Oncology;2021-04